Key Takeaways
- Strong quarter, margin pivot declared: Total income grew 55% YoY to ₹910 cr and EBITDA rose 69% YoY, but the defining move was a deliberate shift to selective order booking that prioritizes margins over market share.
- Old fixed-price contracts are the margin drag, and they are nearly done: Commodity-price pressure on legacy orders should unwind by Q4 or early Q1, setting up a margin trajectory change from FY24 if external factors hold.
- The ethanol story is broadening beyond EBP20: Management sees flex-fuel vehicles and additional consumption channels putting ethanol demand on a "very, very different platform," making the EBP20-only view "myopic."
- CBG and SAF are the medium-to-long-term hedges: The Union Budget's 500-plant GOBARdhan scheme and 5% CBG mandate, plus the Axens SAF MoU, are being built as growth options if ethanol demand falters.
- What to watch next quarter: Whether the old fixed-price order book actually closes out by Q4, the pace of CBG policy detail from the government, and any new 2G order intake once the IOCL Panipat plant begins commercial production.
The Margin Pivot: Old Contracts, New Discipline
- Legacy drag identified: Old fixed-price contracts faced commodity-price pressure; those orders are now coming to closure, with all expected to finish by Q4 and a small portion in Q1.
- Selective order booking implemented: The company became "very, very selective" on order intake this quarter, especially for new segments where promoters are completely new, evaluating their seriousness after debating the market-share-versus-margin trade-off over several quarters.
- Positive impact still pending: The margin benefit from the new selective strategy is yet to flow through because the company is still executing old orders with some backlog.
- Standalone profit clarity: Standalone PAT moved from ~₹34 cr in Q3 FY22 (excluding a ₹30 cr one-time dividend from a subsidiary) to ₹55 cr in Q3 FY23, a genuine profit improvement once the dividend distortion is removed.
Sachin Raole: "We believe that all the old orders should get over by quarter 4 and some portion in quarter 1. So, the trajectory of margin, if all things remain the way in which they are right now, especially the external factors, we will see the change in the margin trajectory from the next financial year."
Ethanol: The Near-Term Engine, and Why EBP20 Is Not the Whole Story
- Domestic order book dominance: Around 75% of orders came for ethanol plants based on starchy feedstock; the sugar sector is showing more optimism for ethanol capacity enhancement, and the same trend is visible in the enquiry basket.
- Sugary feedstock expected to lead: Going forward, management expects sugary-feedstock-based ethanol plants to dominate future capacity creation.
- Flex-fuel vehicles as a demand catalyst: Multiple players announced flex-fuel vehicles at the Auto Expo, giving confidence that the percentage of flex-fuel vehicles will be on the higher side, adding to ethanol demand; the auto industry is looking for a government mandate with a timeline.
- E20 timeline is a trial, not an acceleration: The government announcement is about making E20 available from 2023 onwards on a trial basis at selected petrol pumps, not advancing the entire 20% target by two years; the full EBP20 program remains targeted for 2025.
- International ethanol emerging: Low-carbon ethanol has emerged as an interesting business opportunity in the USA; the company is working on a few leads maturing beyond the enquiry stage and recently completed engineering audits for several ethanol plants in the USA to help producers finalize investment decisions.
- Capacity pipeline: 450–500 cr liters of ethanol capacity creation will come up over a period of time.
Sachin Raole: "So, if you look at only from the EBP20 angle, yes it is myopic according to me. We will have to see the additional channels, which will get opened up on the convention of ethanol will put up canvass of demand on a very, very different platform."
CBG: Policy Tailwinds, but Details Are the Gate
- Budget gave a clear signal: The Union Budget 2023-24 announced 500 new waste-to-wealth plants under the GOBARdhan scheme including 200 CBG plants, a 5% CBG mandate, excise duty exemption on GST-paid compressed bio gas, and fiscal support for biomass collection and bio-manure distribution.
- First rice-straw commercial plant nearing completion: Mechanical completion is expected by end of March 2023; the company is investing in R&D for processing different feedstock combinations based on learnings from two commercial-scale CBG plants commissioned earlier this year.
- Investment details still awaited: Management is waiting for clarity on whether the ₹10,000 cr investment will take the form of subsidy or viability funding, and the modus operandi for funding, before deciding participation based on the nature and size of plants.
- Policy shape uncertain but direction positive: Whether CBG policy takes the same shape as ethanol (mandate and buyback arrangement with OMCs) is yet to be seen, but the government is interested in introducing CBG the way ethanol was introduced.
- Market share ambition is qualitative: Management says it is too early to say whether market share will be 50% or 10%; the competitive landscape is evolving with multiple competitors, and the company wants to play a "meaningful and leading role."
Sachin Raole: "The opportunity right now, the details are still awaited. How this budget has spilled out around INR 10,000 crores of investment. How it is going to be made, whether it will be in a form of any kind of a subsidy or viability funding, we are still awaiting the details on this front..."
2G Ethanol: Waiting on the First Commercial Trigger
- IOCL Panipat plant is the catalyst: Mechanical completion is achieved and the plant is technically ready; pre-commissioning activities are underway section by section, with commercial production expected in the next couple of months.
- Order book stalled pending proof of operation: No new 2G orders were booked in the last quarter; management hopes and expects that once the first commercial plant starts operation, momentum will follow, but right now only a very small component remains pending for servicing existing orders.
- Three commercial-scale orders executing: One is in an advanced stage; two might be a year down the line. No new 2G orders have been announced in the domestic market.
- European discussions advancing: Discussions are progressing positively with various prospects regarding the technology offering in Europe.
SAF, Hydrogen, and the Medium-to-Long-Term Optionality
- SAF MoU with Axens: The arrangement is complementary to the existing Gevo partnership: Gevo covers the first leg (molasses to isobutanol conversion, adapted from corn technology), Axens covers the last leg (conversion to SAF, including ethanol-to-SAF). Ethanol will be low-carbon ethanol.
- SAF market is ex-India initially: European and US markets are already committing to SAF; India has no blending mandate yet, so SAF manufacturing facilities will be outside India initially, with domestic mandates expected in the medium term.
- Hydrogen is early-stage preparation: Management says it is too early to say what will happen and a road map is yet to come; Praj is preparing on multiple fronts including the energy side and equipment side, investing in modularized equipment offerings for hydrogen manufacturing.
- Bio-Prism RCM is a different business model: Product development is progressing positively with the first couple of products showing encouraging results, but business models are still being figured out; the nature of this business is different from ethanol or CBG.
- Portfolio logic: All MoUs entered into are meant for medium-to-long-term scenarios, not quarter-to-quarter; they are being developed to keep the growth trajectory positive if something goes wrong with EBP20 or ethanol demand.
Sachin Raole: "So, these are the three system if something goes wrong, EBP20 or if anything happens, and no, no further demand coming up on the ethanol side, we are keeping all our options ready with all other avenues which will actually give up the growth trajectory which we are looking for."
Order Book, Execution, and the New Manufacturing Bet
- Order book becoming more balanced: The order book is becoming more all-rounded and not concentrated on one business; on an annualized basis, order booking is expected to be on the healthy side to maintain growth momentum.
- Quarterly lumpiness is normal: Order closures in the project business need not happen sequentially; the inquiry basket is "absolutely robust" but sometimes takes time for closure.
- Execution cadence shifting: Historically H1 was lower and H2 higher, but now a trend of more even quarter-on-quarter execution is emerging; Q4 is generally good and expected to remain good.
- Revenue run-rate ambition: The endeavor is to maintain the ₹950–1,000 cr run rate.
- New manufacturing subsidiary: A ₹100 cr investment is planned for a new manufacturing facility because the existing Kandla facility expansion is not sufficient for demand from the critical equipment segment, driven by green energy, CNG, and LNG investments; manufacturing cannot be outsourced, and demand is expected to develop over the next 2 to 3 years.
- Services and O&M building: Good traction in domestic consumables and performance enhancers; international is taking time because demonstrations are needed during the sugar season. O&M orders (2–3 booked in Q3) are being offered in Bioenergy as preparedness for future CBG and 2G opportunities.
Sachin Raole: "It is a long kind of a fall, and we have to see from a longish nature how the order closures are happening. We are seeing a trend continuously, mainly from the inquiry basket point of view, that inquiry basket is absolutely robust. Yes, sometimes it takes some time from the closure of those orders and that's what is actually happening."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Old fixed-price contract closure | All old orders should get over; some portion may spill into Q1 | By Q4 FY23 / early Q1 FY24 |
| Margin trajectory change | Change in margin trajectory expected if external factors remain the same | From next financial year (FY24) |
| CBG rice-straw plant mechanical completion | First rice-straw-based commercial plant | By end of March 2023 |
| IOCL Panipat 2G plant commercial production | Commercial production to begin | Next couple of months |
| New manufacturing subsidiary investment | ₹100 cr for new facility to address ETCA sector | Demand expected to develop over next 2–3 years |
| Revenue run-rate | Endeavor to maintain ₹950–1,000 cr quarterly run rate | Ongoing |
| EBP20 full program target | Government target for 20% blended petrol | 2025 |
Key Metrics
| Metric | Q3 FY23 |
|---|---|
| Total income from operations | ₹909.97 cr, +55% YoY |
| EBITDA | ₹86.16 cr, +69% YoY |
| PBT | ₹85.90 cr, +71% YoY |
| PAT | ₹62.31 cr, +68% YoY (vs ₹37.05 cr in Q3FY22) |
| Standalone PAT | ₹55 cr, up from ₹34 cr in Q3FY22 (ex-dividend of ₹30 cr) |
| Export revenue share | 17% of total revenue |
| Revenue mix | Bio-energy 72.7%, Engineering 19.6%, PHS 7.7% |
| Order intake | ₹944 cr, 83.4% domestic |
| Order intake mix | Bio-energy 81.9%, Engineering 9.6%, PHS 8.5% |
| Order backlog | ₹3,380 cr, 87.5% domestic |
| Cash in hand | ₹604 cr as of December 31, 2022 |
| Ethanol blending rate | ~12%, up from prior levels |
| Market share (ethanol) | ~50%, down from prior ~60% as strategy shifts toward margin selectivity |
| PHS high-capacity fermenter share of OB | 20% of total order book in FY23 |
| CBG mandate | 5% blending mandate introduced for all organizations marketing natural and bio gas |